Transient hyperproinsulinemia during treatment with clozapine and amisulpride.
Maria A
MA
Rettenbacher
Martina
M
Hummer
W Wolfgang
WW
Fleischhacker
Monika
M
Lechleitner
D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007328:Insulin / Q000096:biosynthesis / Q000097:blood; D008152:Loxapine / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D011384:Proinsulin / Q000097:blood* / Q000378:metabolism; D012563:Schizophrenia, Paranoid / Q000097:blood* / Q000188:drug therapy*; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D014150:Antipsychotic Agents; D001786:Blood Glucose; D007328:Insulin; D013469:Sulpiride; D000077582:Amisulpride; D011384:Proinsulin; D008152:Loxapine